Latest News

Friday, September 30, 2016 | Clinical Trials,Retina, Regeneron Pharmaceuticals

Combination Therapy Shows No Benefit Over Aflibercept Alone in Phase 2 AMD Trial

The phase 2 CAPELLA study evaluating aflibercept (Eylea, Regeneron) coformulated with rinucumab (Regeneron), an anti-platelet-derived growth factor (anti-PDGF) receptor beta antibody, in patients with…

Read the full story

Friday, September 30, 2016 | Recalls, Bausch+Lomb

Voluntary Recall of PeroxiClear 3% Hydrogen Peroxide Cleaning & Disinfecting Solution in the US and Canada

Bausch + Lomb is conducting a voluntary recall, proposed Class II, of PeroxiClear 3% Hydrogen Peroxide Cleaning & Disinfecting solution in the United States and Canada. PeroxiClear is a specialty …

Read the full story

Friday, September 30, 2016 | Product Releases

A Swift, Economical Technique for Imaging Multicore Fibers in Real Time

Multicore fibers (MCF) have attracted much attention in the fields of telecommunications, fiber lasers and medical endoscopes. MCF-based optical imaging techniques, which use a fiber bundle (each fibe…

Read the full story

Friday, September 30, 2016 | Medical Studies

Ranibizumab Effective for Pigment Epithelial Detachment

According to a recent study, pigment epithelial detachments (PEDs) of any size can be effectively treated with monthly or pro re nata [PRN] injections of ranibizumab in patients with neovascular age-r…

Read the full story

Friday, September 30, 2016 | Medical Studies

On-Site, Telemedicine Views on Infants' Eyes May Differ

Evaluating acute-phase retinopathy of prematurity (ROP) by direct clinical examination may produce different results from evaluations done via telemedicine, according to new findings. As Dr. Graham E.…

Read the full story

Thursday, September 29, 2016 | Partnerships, Bayer

DelSiTech and Bayer Partner to Develop Innovative Drug Delivery Technology for Ophthalmology

DelSiTech Ltd, a Finnish drug delivery technology and drug development company, and Bayer have signed a collaboration and technology licence agreement for the worldwide application of DelSiTech’…

Read the full story

Thursday, September 29, 2016 | Product Releases, Abbott Medical Optics, AMO

Abbott Releases Tecnis Toric Calculator With Posterior Corneal Astigmatism Compensation

Abbott received FDA approval of a new toric calculator with posterior corneal astigmatism (PCA) compensation. The addition of PCA compensation eliminates the need for look-up tables and improves the p…

Read the full story

Wednesday, September 28, 2016 | Health Care, Essilor

Essilor Launches a Plan to Enable 50% of Employees Worldwide to Become Shareholders

Essilor International’s board of directors has approved an ambitious plan to promote employee shareholding, with the long-term objective to see 50% of employees worldwide become shareholders of …

Read the full story

Wednesday, September 28, 2016 | Health Care

Evidence Links Vision Benefits to Healthy Vision Habits, NAVCP Reports

With the annual open enrollment period set to begin for millions of Americans over the next several weeks, the National Association of Vision Care Plans (NAVCP) is stepping up to emphasize the correla…

Read the full story

Wednesday, September 28, 2016 | Product Releases,Retina

Cellular Dynamics International Launches Opsis Therapeutics to Develop Cell Therapies for Treatment of Retinal Diseases

Cellular Dynamics International, a FUJIFILM company and a developer and manufacturer of induced pluripotent stem cell (iPSC) products, announced a new venture, named Opsis Therapeutics. Formed on July…

Read the full story

Wednesday, September 28, 2016 | Product Releases, Avedro

First FDA Approved Cross-Linking Procedures Are Performed on Patients in the US with Progressive Keratoconus

Avedro announced that it is now shipping Photrexa Viscous and Photrexa, the drugs used in corneal cross-linking procedures with the KXL System. On April 15, 2016, Avedro received approval from the …

Read the full story

Tuesday, September 27, 2016 | Health Care

USC Roski Eye Institute Joins The National Academies in Call to Public Policy Health Leaders for Population Health Transformation

A report issued by the National Academies of Sciences, Engineering and Medicine (NASEM), "Making Eye Health a Population Health Imperative: Vision for Tomorrow," offers a clear lens into hea…

Read the full story

Tuesday, September 27, 2016 | Management/Leadership, OPKO Health

Opko Health Appoints Dr. Benjamin Solomon as Managing Director of GeneDx

Opko Health announced the appointment of Benjamin D. Solomon, MD, as Managing Director of GeneDx, effective October 3, 2016. GeneDx, part of OPKO’s BioReference Laboratories subsidiary, spec…

Read the full story

Tuesday, September 27, 2016 | Glaucoma,Medical Studies, Glaukos Corporation

New Study Underscores Ability of iStent to Achieve Sustained Reductions in IOP and Medication Use

A study published in Clinical Ophthalmology showed that a consistent cohort of 107 open-angle glaucoma (OAG) eyes receiving the iStent Trabecular Micro-Bypass Stent in combination with cataract surger…

Read the full story

Monday, September 26, 2016 | Miscellaneous, Sun Pharma

Sun Pharma Hosting Symposium on Managing Ocular Pain and Inflammation after Cataract Surgery

Sun Pharma is hosting a symposium titled "Managing Ocular Pain and Inflammation After Cataract Surgery: Differentiating Among the Non-Steroidal Anti-Inflammatory Drugs" on Saturday, October …

Read the full story
Load More